Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Trend Investment Group

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 25
Average round size
info
The average size of a deal this fund participated in
$4M
Portfolio companies 21
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.16
Exits 1
Key employees 1

Areas of investment

  • Biotechnology
  • Health Care
  • Biopharma
  • Medical
  • Therapeutics
Summary

The typical case for the fund is to invest in rounds with 3-4 participants. The meaningful sponsors for the fund in investment in the same round are Oriza Seed Capital (Oriza Yuandian), Decheng Capital, Craig Fletcher. In the next rounds fund is usually obtained by South China Venture Capital, Sherpa Venture Capital, SDIC Fund Management.

Among the most popular portfolio startups of the fund, we may highlight EpimAb Biotherapeutics. Besides, a startup requires to be at the age of 2-3 years to receive the investment from the fund. We can highlight the next thriving fund investment areas, such as Health Care, Software Engineering.

The overall number of key employees were 1.

The fund is generally included in less than 2 deals every year. The high activity for fund was in 2017. Deals in the range of 10 - 50 millions dollars are the general things for fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Trend Investment Group:
Typical Co-investors
Trend Investment Group is more likely to invest in rounds together with the following funds:
There are no funds here. If we find new data, we will add it here.
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Trend Investment Group:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Accelerate Long Island Melville, New York, United States
AMKA Holdings Canada, Ontario, Toronto
Arab Bank (Switzerland) Geneva, Geneve, Switzerland
BioSciKin -
Coghill Capital Management Chicago, Illinois, United States
Coris Bank International Burkina Faso, Kadiogo, Ouagadougou
CyRise Australia, Melbourne, Victoria
DPE Deutsche Private Equity Bayern, Germany, Munich
East Coast Ventures -
Elevance Renewable Sciences Illinois, United States, Woodridge
i-nest capital Japan, Tokyo
Lauxera Capital Partners France, Ile-de-France, Paris
Monex Precious Metals California, Newport Beach, United States
Roma Way China, Harbin, Heilongjiang
SeedRocket 4Founders Capital Barcelona, Catalonia, Spain
ShoreTel California, Sunnyvale, United States
Smartforce -
Talkot Capital California, Sausalito, United States
Varagon Capital Partners New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Mogrify

Big Data
Bioinformatics
Biotechnology
Health Care
Life Science
Therapeutics
$10M02 Oct 2023 Cambridge, England, United Kingdom

MindImmune Therapeutics

Biotechnology
Neuroscience
Pharmaceutical
$12M30 Jun 2022 Rhode Island, United States

Senisca

Biotechnology
$2M09 Jun 2022 Exeter, England, United Kingdom

PragmatIC Semiconductor

Electronics
Foundries
Internet of Things
Product Design
Semiconductor
01 Jan 2022 Cambridge, England, United Kingdom

Mogrify

Big Data
Bioinformatics
Biotechnology
Health Care
Life Science
Therapeutics
03 Sep 2021 Cambridge, England, United Kingdom

Astrocyte Pharmaceuticals

Biotechnology
Clinical Trials
Pharmaceutical
Therapeutics
$6M03 May 2021 Cambridge, Massachusetts, United States

PhoreMost

Biopharma
Biotechnology
Health Care
$45M23 Mar 2021 Cambridge, England, United Kingdom

Biotechnology
$1M05 Mar 2021 Exeter, England, United Kingdom

Keythera Pharmaceuticals

12 Feb 2021 Gusu District, Jiangsu, China
News
PhoreMost Raises $46M in Series B Financing

– PhoreMost is a Cambridge, England, UK-based biopharmaceutical company.
– The company raised $46m in Series B funding.
– The round was led by BGF, and included new investor – XtalPi Inc., Astellas Venture Management, Trend Investment Group, and o2h ventures.
– Existing investors Parkwalk Advisors, Morningside Ventures, and Jonathan Milner also contributed.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Trend Investment Group?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 25
Average round size 4M
Peak activity year 2017
Lead investments 1
Follow on index 0.16
Exits 1
Group Appearance index 0.32

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

Mogrify

Big Data
Bioinformatics
Biotechnology
Health Care
Life Science
Therapeutics
$10M02 Oct 2023 Cambridge, England, United Kingdom

MindImmune Therapeutics

Biotechnology
Neuroscience
Pharmaceutical
$12M30 Jun 2022 Rhode Island, United States

Senisca

Biotechnology
$2M09 Jun 2022 Exeter, England, United Kingdom

PragmatIC Semiconductor

Electronics
Foundries
Internet of Things
Product Design
Semiconductor
01 Jan 2022 Cambridge, England, United Kingdom

Mogrify

Big Data
Bioinformatics
Biotechnology
Health Care
Life Science
Therapeutics
03 Sep 2021 Cambridge, England, United Kingdom

Astrocyte Pharmaceuticals

Biotechnology
Clinical Trials
Pharmaceutical
Therapeutics
$6M03 May 2021 Cambridge, Massachusetts, United States

PhoreMost

Biopharma
Biotechnology
Health Care
$45M23 Mar 2021 Cambridge, England, United Kingdom

Biotechnology
$1M05 Mar 2021 Exeter, England, United Kingdom

Keythera Pharmaceuticals

12 Feb 2021 Gusu District, Jiangsu, China
Crunchbase icon

Content report

The following text will be sent to our editors: